Herriott James, General Counsel at Exact Sciences Corporation (EXAS), has demonstrated a clear pattern of selling activity based on SEC Form 4 filings. Over 39 reported transactions, James has sold shares totaling $5,507,399.51, with minimal buying activity amounting to just $2,041.36. This significant disparity highlights a strong bias toward divesting his holdings in the company. All transactions have been concentrated in EXAS, indicating a focus on his primary equity position.
Recent filings underscore this trend. On December 23, 2025, James executed multiple sales under code "F," with values ranging from $78,910.50 to $1,449,407.70, collectively amounting to millions of dollars. These transactions were accompanied by smaller sales earlier in November 2025, including a $70,000 transaction on November 19. Notably, there have been no recent purchases, with the last buy activity occurring well before the recent sales.
The absence of buying activity and the substantial volume of sales suggest a deliberate reduction in James’s equity stake in Exact Sciences. While the reasons behind these transactions are not disclosed in the filings, the data reflects a consistent and significant divestment strategy over time. This pattern aligns with his broader trading history, which has been overwhelmingly weighted toward selling since his earliest reported transactions.
AI-assisted summary